Advertisement

Adenylate Cyclase from Various Dopaminergic Areas of the Brain and the Action of Loxapine

  • Yvonne C. Clement-Cormier
Part of the Advances in Experimental Medicine and Biology book series (AEMB)

Abstract

The present report is a comparative study of adenylate cyclase activity in various areas of the brain identified as dopaminergic. Low levels of dopamine were found to stimulate adenylate cyclase from the striatum, median eminence, olfactory tubercle, nucleus accumbens and amygdala. Apomorphine, known to mimic the pharma cological and physiological effects of dopamine, stimulated adenylate cyclase from these areas. Several different classes of drugs effective in the treatment of schizophrenia were potent inhibitors of the stimulation by dopamine of the enzyme from these various regions. The drugs studied included representatives of the phenothiazine, butyrophenone, dibenzodiazepine and dibenzoxazepine classes. The inhibition by the dibenzoxazepine, loxapine, which is structurally very similar to the dibenzodiazepine, clozapine, was competitive with respect to dopamine. The calculated inhibition constant (Ki) for loxapine of about 15 nM was similar to that observed for some of the more potent phenothiazines. The results, considered together with previously published data, support the possibility that the therapeutic effects as well as the extrapyramidal and endocrinological side effects, of these antipsychotic agents may be attributable to their ability to block the activation of adenylate cyclase in various select areas of the brain.

Keywords

Dopamine Receptor Nucleus Accumbens Adenylate Cyclase Antipsychotic Drug Caudate Nucleus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bjorklund, A. Moore, R.Y. Norbin, A. and Stenevi, U. (1974). The organization of Tubero-hypophyseal and reticulo-infundibular catecholamine neuron systems in the rat brain. Brain Research 51 ,171–191.CrossRefGoogle Scholar
  2. Carlsson, A. and Lindquist, M. (1963). Effect of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetane phrine in mouse brain. Acta Pharmacol ,et Toxicol. 20 ,140–144.CrossRefGoogle Scholar
  3. Chen, Y.-C. and Prusoff, W.H. (1973). Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (150. of an enzymatic re action. Biochem. Pharmacol. 22 ,3099–3108.Google Scholar
  4. Clement-Cormier, Y.C., Kebabian, J.W., Petzold, G.L. and Greengard, P. (1974). Dopamine-sensitive adenylate cyclase in mammalian brain: 2 possible site of action of antipsychotic drugs. Proc. Nat. Acad. Sci. 71 ,1113–1117.PubMedCrossRefGoogle Scholar
  5. Clement-Cormier, Y.C., Parrish, R.G., Petzold, G.L., Kebabian, J.W. and Greengard, P. (1975). Characterization of a dopaminesensitive adenylate cyclase in the rat caudate nucleous. J. New>ochem. 25 ,143–149.CrossRefGoogle Scholar
  6. Coupet, J. and Szucs, V.A. (1976). The effects of loxapine and its metabolites on the dopamine-sensitive adenyl cyclase of rat striatal homogenates. Fed. Proc. 35 ,456.Google Scholar
  7. Hollister, L.E. (1973). Clinical Use of Psychotherapeutic Drugs. C.C. Thomas, Springfield, Illinois.Google Scholar
  8. Hornykiewicz, O. (1971). Neurochemical pathology and pharmacology of brain dopamine and acetylcholine: Rational basis for the current drug treatment of parkinsonism. Contemp. Neurol. Series. 8 ,34–65.Google Scholar
  9. Hornykiewicz, O. (1966). Dopamine (3-hydroxytyramine) and brain function. Pharmacol. Rev. 18 ,925–964.PubMedGoogle Scholar
  10. Karobath, M. and Leitich, H. (1974). Antipsychotic drugs and dopamine-stimulated adenylate cyclase prepared from corpus stria turn of rat brain. Proc. Nat. Acad. Sci. USA 71 ,2915–2918.PubMedCrossRefGoogle Scholar
  11. Kavanagh, A. and Weisz, J. (1973). Localization of dopamine and norepinephrine in the medial basal hypothalamus in the rat. Neuroendocrinology 13 ,201–212.PubMedCrossRefGoogle Scholar
  12. Kebabian, J.W., Petzold, G.L. and Greengard, P. (1972). Dopaminesensitive adenylate cyclase in caudate nucleos of rat brain, and its similarity to the “dopamine receptor”. Proc. Nat. Aoad. Sci. USA 69 ,2145–2149.CrossRefGoogle Scholar
  13. Konig, J. and Knippel, R. (1970). The Rat Brain, A Stereotoxic Atlas of the Forebrain and Lower Parts of the Brainstem. Krieger, New York.Google Scholar
  14. Lowry, O.H., Rosebrough, N.J., Farr, A.L. and Randall. R.J. (1951). Protein measurement with the folin phenol reagent. J. Biot. Chem. 193 ,265–275.Google Scholar
  15. Martin, J.B. (1973). Neural regulation of growth hormone secretion. New Engt. J. Med. 288 ,1384–1393.CrossRefGoogle Scholar
  16. Miller, R.J., Horn. A.S. and Iverson. L.L., (1974). The action of neuroleptic drugs on dopamine-stimulated adenosine cyclic 31,51- monophosphate production in rat striatum and limbic forebrain. Mol. Pharmacol. 10 ,759–766.Google Scholar
  17. Nyback, H. and Sedvall, G. (1968). Effect of chlorpromazine on accumulation and disappearance of catecholamines formed from tyrosine -14 C in the brain. J. Pharmacol. Exp. Ther. 162 ,294–301.PubMedGoogle Scholar
  18. Thierry, A.M., Blanc, G. Sabel, A., Stinus, L. and Glowinski, J. (1973). Dopamine terminals in the rat cortex. Science 182 ,499–501.PubMedCrossRefGoogle Scholar
  19. Ungerstedt, U.1971). Postsynaptic supersensitivity after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol. Scand. 367 (1): 69–94.Google Scholar

Copyright information

© Plenum Press, New York 1977

Authors and Affiliations

  • Yvonne C. Clement-Cormier
    • 1
  1. 1.Department of PharmacologyThe University of Texas Medical School at HoustonHoustonUSA

Personalised recommendations